Dachaigh › Aillse a' bhroilleach › North Carolina › Durham
Sgrùdaidhean clionaigeach Aillse a' bhroilleach ann an Durham, NC
Tha 64 sgrùdaidhean airson Aillse a' bhroilleach a’ lorg phàirtichean aig làraichean ann agus timcheall air Durham (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
The Vanguard Study: Testing a New Way to Screen for Cancer
A’ fastadhFàilte do shaor-thoilich fhallain
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
A Study of PHST001 in Advanced Solid Tumors
A’ fastadhÌre 1
- Duke Cancer Institute, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
A’ fastadhÌre 1/2
- Duke University, Durham
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
A’ fastadhÌre 3
- Duke Cancer Network, Durham
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Durham VA Medical Center, Durham
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
- University of North Carolina, Chapel Hill · 10 mìle air falbh
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
A’ fastadhÌre 2
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · 10 mìle air falbh
Radiation Therapy and Thymus Function in Young Women With Breast Cancer
A’ fastadhSgrùdadh amharc
- Duke Cancer Center, Durham
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
A’ fastadhÌre 1
- Duke Cancer Center, Durham
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- University of North Carolina, Chapel Hill · 10 mìle air falbh
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
A’ fastadhÌre 2
- Duke Cancer Institute, Durham
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
A’ fastadhÌre 3
- Clinical Trial Site, Durham
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
A’ fastadhÌre 1
- Duke University Medical Center, Durham
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A’ fastadhÌre 3
- University of North Carolina Medical Center, Chapel Hill · 10 mìle air falbh
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
A’ fastadhÌre 2
- University of North Carolina Medical Center, Chapel Hill · 10 mìle air falbh
Identifying Patterns in the Breath of Individuals With Breast Cancer
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Duke University Medical Cente, Durham
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
A’ fastadhÌre 2
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mìle air falbh
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
A’ fastadhÌre 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 mìle air falbh
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A’ fastadhÌre 3
- Duke Cancer Institute, Durham
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
A’ fastadhSgrùdadh amharc
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mìle air falbh
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
A’ fastadhÌre 1/2
- Duke Cancer Institute, Durham
A Phase 1/1b Study of IAM1363 in HER2 Cancers
A’ fastadhÌre 1
- Duke Cancer Institute, Durham
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
A’ fastadhÌre 1/2
- Duke Cancer Institute, Durham
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
A’ fastadhÌre 3
- Duke Cancer Institute, Durham
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
A’ fastadhÌre 2
- Duke University, Durham
Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
A’ fastadhÌre 2
- University of North Carolina, Chapel Hill · 10 mìle air falbh
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
A’ fastadhÌre 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
- University of North Carolina-Hillsborough Campus, Hillsborough · 13 mìle air falbh
Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
A’ fastadhFàilte do shaor-thoilich fhallain
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
A’ fastadhÌre 2
- University of North Carolina, Chapel Hill · 10 mìle air falbh
Optimizing Surgical Decisions in Young Adults With Breast Cancer
A’ fastadh
- Duke Cancer Institute, Durham
A Novel Approach Utilizing Organ Specific Age Proteomics
A’ fastadhSgrùdadh amharc
- University of North Carolina, Chapel Hill · 10 mìle air falbh
Weight Management After Cancer for Survivors in Rural Communities
A’ fastadh
- Duke University Medical Center, Durham
Behavioral Pain Intervention for Older Cancer Patients
A’ fastadh
- Duke Cancer Network, Durham
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
A’ fastadhÌre 2/3
- Duke Cancer Institute, Durham
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
A’ fastadh
- Duke University/Duke Cancer Center, Durham
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
A’ fastadhÌre 2
- Duke University Medical Center, Durham
Planning Grant for TOPS for Breast Cancer Survivors
A’ fastadh
- Duke University, Durham
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
A’ fastadhÌre 1
- University of North Carolina, Chapel Hill · 10 mìle air falbh
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
A’ fastadh
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · 10 mìle air falbh
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
A’ fastadh
- Duke Cancer Institute (Data collection only), Durham
- Duke Cancer Institute (Data collection only), Durham
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
A’ fastadhSgrùdadh amharc
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mìle air falbh
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
A’ fastadhÌre 3
- Duke University Medical Center, Durham
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
A’ fastadhÌre 1
- University of North Carolina, Chapel Hill · 10 mìle air falbh
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
- The University of North Carolina, Chapel Hill · 10 mìle air falbh
VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients
A’ fastadhSgrùdadh amharc
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mìle air falbh
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
A’ fastadhÌre 2
- University of North Carolina, Chapel Hill · 10 mìle air falbh
Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
A’ fastadh
- University of North Carolina, Chapel Hill · 10 mìle air falbh
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
A’ fastadhÌre 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 mìle air falbh
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
A’ fastadhÌre 2
- The University of North Carolina at Chapel Hill, Chapel Hill · 10 mìle air falbh
Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
A’ fastadhÌre 2
- University of North Carolina, Chapel Hill · 10 mìle air falbh
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
A’ fastadhÌre 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
A’ fastadh
- Duke University, Durham
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
A’ fastadhÌre 1/2
- Duke Cancer Center/ DUMC, Durham
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
A’ fastadhSgrùdadh amharc
- UNC, Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
A’ fastadhÌre 2
- University of North Carolina, Chapel Hill · 10 mìle air falbh
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
A’ fastadhÌre 1
- Duke Cancer Institute, Durham
Nutrition Awareness Among Women With Non-Metastatic Breast Cancer
A’ fastadh
- UNC Cancer Hospital, Chapel Hill · 10 mìle air falbh
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
A’ fastadh
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
A’ fastadh
- Duke Cancer Institute, Durham
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
A’ fastadh
- Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill, Chapel Hill · 10 mìle air falbh
BREAST Choice Decision Tool R21 - AIM2
A’ fastadhFàilte do shaor-thoilich fhallain
- The University of North Carolina, Chapel Hill · 10 mìle air falbh
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
A’ fastadh
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mìle air falbh
UNC Pleural Fluid Registry
A’ fastadhSgrùdadh amharc
- UNC Lingeberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
Sgrùdaidhean Aillse a' bhroilleach ann am bailtean eile
- New York City, NY136 sgrùdaidhean
- Houston, TX126 sgrùdaidhean
- Boston, MA112 sgrùdaidhean
- Nashville, TN81 sgrùdaidhean
- Los Angeles, CA73 sgrùdaidhean
- Edison, NJ68 sgrùdaidhean
- St. Louis, MO64 sgrùdaidhean
- Queens, NY64 sgrùdaidhean
- Chicago, IL59 sgrùdaidhean
- Philadelphia, PA56 sgrùdaidhean
- Dallas, TX55 sgrùdaidhean
- Arlington, VA47 sgrùdaidhean
Sgrùdaidhean eile ann an Durham
- Aillse (gach seòrsa)58 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag39 sgrùdaidhean
- Myeloma iomaill37 sgrùdaidhean
- Leukemia myeloid geur33 sgrùdaidhean
- Ailse metastatach33 sgrùdaidhean
- Aillse Prostata32 sgrùdaidhean
- Ailseachadh nan Sgamhan32 sgrùdaidhean
- Aillse colorectal28 sgrùdaidhean
- Cancer Ovarian27 sgrùdaidhean
- Leukemia Lymphocytic Cronach27 sgrùdaidhean
- Fàilligeadh a' Chridhe26 sgrùdaidhean
- Cancer Pancreatic24 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.